Cancers (Dec 2022)

The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma

  • Dalia Fahmy,
  • Ahmed Alksas,
  • Ahmed Elnakib,
  • Ali Mahmoud,
  • Heba Kandil,
  • Ashraf Khalil,
  • Mohammed Ghazal,
  • Eric van Bogaert,
  • Sohail Contractor,
  • Ayman El-Baz

DOI
https://doi.org/10.3390/cancers14246123
Journal volume & issue
Vol. 14, no. 24
p. 6123

Abstract

Read online

Hepatocellular carcinoma (HCC) is the most common primary hepatic neoplasm. Thanks to recent advances in computed tomography (CT) and magnetic resonance imaging (MRI), there is potential to improve detection, segmentation, discrimination from HCC mimics, and monitoring of therapeutic response. Radiomics, artificial intelligence (AI), and derived tools have already been applied in other areas of diagnostic imaging with promising results. In this review, we briefly discuss the current clinical applications of radiomics and AI in the detection, segmentation, and management of HCC. Moreover, we investigate their potential to reach a more accurate diagnosis of HCC and to guide proper treatment planning.

Keywords